Pharmacy Search
Vertice Login
Menu
close

Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

Medication Type: Erectile Dysfunction

Stendra® (avanafil) tablets

Approval Date: Jun 2024

Note: First-Time Generic

Indicated for the treatment of erectile dysfunction

Chewtadzy™ (tadalafil) chewable tablets

Approval Date: Jun 2024

Note: New Product

A new chewable tablet indicated for the treatment of erectile dysfunction, and the signs and symptoms of benign prostatic hyperplasia

Medication Name

Approval Date

Category

Description

Stendra® (avanafil) tablets

Jun 2024

Indicated for the treatment of erectile dysfunction

Note: First-Time Generic

Chewtadzy™ (tadalafil) chewable tablets

Jun 2024

A new chewable tablet indicated for the treatment of erectile dysfunction, and the signs and symptoms of benign prostatic hyperplasia

Note: New Product
lockenvelopephone-handsetmagnifiermenucross-circle